4//SEC Filing
Terrillion Scott 4
Accession 0001209191-22-023249
CIK 0001346830other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:51 PM ET
Size
5.2 KB
Accession
0001209191-22-023249
Insider Transaction Report
Form 4
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
- Sale
Common Stock
2022-04-01$11.91/sh−1,642$19,556→ 102,344 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on April 1, 2021, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001706426
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:51 PM ET
- Size
- 5.2 KB